EXCELLENT SUMMARY JJ !
Longs, the delays are trivial compared to the progress being made .
Dr . Missling did predict that 3 trials would start in 2017 , HOWEVER the FDA / Dr Gottlieb ALSO predicted that They would issue 10 new guidance reps , including 5 CNS , by end of 2017 - - this “ promise “ was also missed .
Both Gottlieb and Missling may have underestimated the gigantic task to achieve the “paradigm shift “ conversion from traditional Clinical trials to ADAPTIVE TRIALS with closer dialogue and interaction between submitting companies and the FDA , HOWEVER ,you can be guaranteed that this close cooperation is occurring with Anavex and FDA !
We are dealing with a REGULATORY AGENCY folks , this is breakneck speed compared with the old system !
For those with no patience , sell and reinvest in Home Depot or Mc D , it will be less stressful.
GLTAL
News 
Market Data 
Discover 
